申请人:Kilburn John Paul
公开号:US20090306048A1
公开(公告)日:2009-12-10
A novel class of compounds of the general formula (I), their use in therapy, pharmaceutical compositions comprising the compounds, as well as their use in the manufacture of medicaments are described. The present compounds modulate the activity of 11β-hydroxysteroid dehydrogenase type 1 (11βHSD1) and are accordingly useful in the treatment of diseases in which such a modulation is beneficial, e.g. the metabolic syndrome.
本文描述了一类新型化合物的一般式(I),它们在治疗中的应用,包括这些化合物的制药组合物以及它们在药物制造中的应用。这些化合物调节11β-羟基类固醇脱氢酶1(11βHSD1)的活性,因此在治疗这种调节有益的疾病(例如代谢综合症)中有用。